Validation of surrogate endpoint biomarkers in prostate cancer chemoprevention trials

This publication has 7 references indexed in Scilit:

• THE OPTIMAL SYSTEMATIC PROSTATE BIOPSY SCHEME SHOULD INCLUDE 8 RATHER THAN 6 BIOPSIES: RESULTS OF A PROSPECTIVE CLINICAL TRIAL
  Journal of Urology, 2000
• Evaluation of biomarker modulation by fenretinide in prostate cancer patients.
  European Urology, 1999
• The Bcl-2 Protein Family: Arbiters of Cell Survival
  Science, 1998
• Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines
  Cancer Letters, 1998
• Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens
  Urology, 1997
• Validation of Intermediate End Points in Cancer Research
  JNCI Journal of the National Cancer Institute, 1990
• BIAS DUE TO MISCLASSIFICATION IN THE ESTIMATION OF RELATIVE RISK
  American Journal of Epidemiology, 1977